# Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)

> **NCT00423280** · PHASE2 · UNKNOWN · sponsor: **University of Oxford** · enrollment: 66 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** 6R-BH4

## Key facts

- **NCT ID:** NCT00423280
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-11
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2008-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00423280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00423280, "Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00423280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*